Why the study?
Microalbuminuria predicts early-stage renal complications and progression to renal dysfunction, but risk factors among patients with type 2 diabetes mellitus required determination.
What are the risk factors for microalbuminuria among patients with type 2 diabetes mellitus in Korea?
What are the risk factors for microalbuminuria among patients with type 2 diabetes mellitus in Korea?
Low hemoglobin level, along with higher systolic blood pressure and fasting blood sugar, and lower HDL cholesterol, is a significant risk factor for microalbuminuria in patients with type 2 diabetes.
Answers are grounded in this paper and cite their sources.
Identifies potential risk markers for microalbuminuria in Korean T2DM; hypothesis-generating and requires longitudinal confirmation before practice change.
Diabetes mellitus is a chronic disease with high economic and social burdens. This study aimed to determine the risk factors of microalbuminuria among patients with type 2 diabetes mellitus. Microalbuminuria is predictive of early-stage renal complications and subsequent progression to renal dysfunction. We collected data on type 2 diabetes patients who participated in the 2019–2020 Korea National Health and Nutrition Examination Survey. The risk factors for microalbuminuria among patients with type 2 diabetes were analyzed using logistic regression. As a result, the odds ratios were 1.036 (95% confidence interval (CI) = 1.019–1.053, p < 0.001) for systolic blood pressure, 0.966 (95% CI = 0.941–0.989, p = 0.007) for high-density lipoprotein cholesterol level, 1.008 (95% CI = 1.002–1.014, p = 0.015) for fasting blood sugar level, and 0.855 (95% CI = 0.729–0.998, p = 0.043) for hemoglobin level. A significant strength of this study is the identification of low hemoglobin level (i.e., anemia) as a risk factor for microalbuminuria in patients with type 2 diabetes. This finding implies that the early detection and management of microalbuminuria can prevent the development of diabetic nephropathy.
No takes yet. Share an insight, caveat, or question.
Bae et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: